We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$115M
AUM Growth
-$80.1M
Cap. Flow
-$107M
Cap. Flow %
-93.27%
Top 10 Hldgs %
68.73%
Holding
65
New
15
Increased
2
Reduced
17
Closed
31

Top Buys

Rank Stock Value
1
A icon
Agilent Technologies
A
+$5.83M
2
IQV icon
IQVIA
IQV
+$3.85M
3
BSX icon
Boston Scientific
BSX
+$3.19M
4
CAH icon
Cardinal Health
CAH
+$2.68M
5
MDT icon
Medtronic
MDT
+$2.34M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$20M
2
BDX icon
Becton Dickinson
BDX
+$16.1M
3
ELV icon
Elevance Health
ELV
+$14.6M
4
SBRA icon
Sabra Healthcare REIT
SBRA
+$13.4M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.18M

Sector Composition

Rank Sector Weight
1 Healthcare 66.02%
2 Real Estate 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVI icon
51
Maravai LifeSciences
MRVI
$946M
– –
-20,753
Closed -$291K
PFE icon
52
Pfizer
PFE
$147B
– –
-73,265
Closed -$2.99M
PTCT icon
53
PTC Therapeutics
PTCT
$5.78B
– –
-53,247
Closed -$2.58M
QURE icon
54
uniQure
QURE
$3.07B
– –
-71,040
Closed -$1.43M
RMD icon
55
ResMed
RMD
$32.5B
– –
-6,345
Closed -$1.39M
SBRA icon
56
Sabra Healthcare REIT
SBRA
$5.32B
– –
-1,165,923
Closed -$13.4M
TEVA icon
57
Teva Pharmaceuticals
TEVA
$40.5B
– –
-762,264
Closed -$6.18M
TMO icon
58
Thermo Fisher Scientific
TMO
$214B
– –
-3,744
Closed -$2.16M
VKTX icon
59
CALL
Viking Therapeutics
VKTX
$3.91B
– –
-442
Closed -$7.36K
XRAY icon
60
Dentsply Sirona
XRAY
$2.76B
– –
-55,992
Closed -$2.2M
ZBH icon
61
Zimmer Biomet
ZBH
$19B
– –
-9,283
Closed -$1.2M
CTLT
62
DELISTED
CATALENT, INC.
CTLT
– –
-9,144
Closed -$601K
GRTS
63
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-540,657
Closed -$1.5M
ISEE
64
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-64,704
Closed -$1.57M
ATNX
65
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-42,651
Closed -$56.7K
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Endurant Capital Management held 65 positions worth $115M, down 41% from $195M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Endurant Capital Management withdrew a net $107M in Q2 2023, closing 31 positions and reducing 17 holdings. Its most notable exit was Sabra Healthcare REIT, an estimated $13.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 92% a quarter earlier, followed by Real Estate.

Against the trend, Endurant Capital Management opened a new position in Agilent Technologies worth $5.5M.

  • Endurant Capital Management's largest Q2 2023 buy was Agilent Technologies: 45,762 shares worth $5.5M.
  • Endurant Capital Management added most to Encompass Health in Q2 2023, an estimated $391K increase.
  • Endurant Capital Management's biggest Q2 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $20M.
  • Endurant Capital Management fully exited Sabra Healthcare REIT in Q2 2023, selling an estimated $13.4M.
  • Endurant Capital Management's ten largest holdings make up 69% of its $115M portfolio in Q2 2023.
  • Endurant Capital Management opened 15 new positions and closed 31 in Q2 2023.
  • Endurant Capital Management's portfolio value fell 41% quarter-over-quarter to $115M.

Based on Endurant Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.